ABSTRACT
The administration of a luteal E2 patch/GnRH antagonist protocol before gonadotropins in poor responders may improve ovarian stimulation and result in greater uniformity in follicular development and improved pregnancy rates.
Subject(s)
Estradiol/administration & dosage , Fertilization in Vitro/methods , Gonadotropin-Releasing Hormone/antagonists & inhibitors , Gonadotropins/administration & dosage , Luteal Phase/drug effects , Adult , Chi-Square Distribution , Female , Humans , Luteal Phase/physiology , Treatment FailureABSTRACT
OBJECTIVE: The purpose of this study was to assess sexual functioning and patient expectations of sexual functioning after hysterectomy. STUDY DESIGN: Seventy-five patients who had undergone hysterectomy at an urban academic medical center were surveyed about sexual function at the time of hysterectomy and after hysterectomy. Chi-squared tests compared responses for discrete outcomes. RESULT: Most patients expected no change in sexual desire or orgasm quality. Hysterectomy had no effect on the frequency of sexual activity or on orgasmic response. Postoperatively, patients were less likely to report pain with intercourse (relative risk, 5.34; 95% CI, 2.2-12.95; P =.00002): 49.3% of patients had discussed sexual functioning after hysterectomy with their physicians, and 64.8% of patients recalled initiating the discussion. CONCLUSION: Most patients expected and experienced no change in sexual desire, orgasm frequency, or orgasm intensity. Hysterectomy appears to result in decreased pain with sexual relations.
